Report Detail

Pharma & Healthcare Global OTC Anti-Infective Products Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3775217
  • |
  • 24 September, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.

Scope of the Report:
The worldwide market for OTC Anti-Infective Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the OTC Anti-Infective Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antifungals
Antiseptic
Antiparasitics

Market Segment by Applications, can be divided into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales, revenue and global market share of OTC Anti-Infective Products in 2017 and 2018.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, OTC Anti-Infective Products market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 OTC Anti-Infective Products Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Antifungals
      • 1.2.2 Antiseptic
      • 1.2.3 Antiparasitics
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Drug Stores
      • 1.3.3 Retail Stores
      • 1.3.4 E-Commerce
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GlaxoSmithKline
      • 2.1.1 Business Overview
      • 2.1.2 OTC Anti-Infective Products Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Merck
      • 2.2.1 Business Overview
      • 2.2.2 OTC Anti-Infective Products Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Merck OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 OTC Anti-Infective Products Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 OTC Anti-Infective Products Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Abbott
      • 2.5.1 Business Overview
      • 2.5.2 OTC Anti-Infective Products Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Abbott OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Sanofi
      • 2.6.1 Business Overview
      • 2.6.2 OTC Anti-Infective Products Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Sanofi OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Bristol-Myers Squibb
      • 2.7.1 Business Overview
      • 2.7.2 OTC Anti-Infective Products Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Roche
      • 2.8.1 Business Overview
      • 2.8.2 OTC Anti-Infective Products Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Roche OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 NanoViricides
      • 2.9.1 Business Overview
      • 2.9.2 OTC Anti-Infective Products Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 NanoViricides OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novabay Pharmaceuticals
      • 2.10.1 Business Overview
      • 2.10.2 OTC Anti-Infective Products Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Optimer Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 OTC Anti-Infective Products Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Basilea Pharmaceutica
      • 2.12.1 Business Overview
      • 2.12.2 OTC Anti-Infective Products Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 MerLion Pharma
      • 2.13.1 Business Overview
      • 2.13.2 OTC Anti-Infective Products Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 MerLion Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global OTC Anti-Infective Products Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global OTC Anti-Infective Products Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global OTC Anti-Infective Products Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2018
      • 3.3.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global OTC Anti-Infective Products Market Analysis by Regions

    • 4.1 Global OTC Anti-Infective Products Sales, Revenue and Market Share by Regions
      • 4.1.1 Global OTC Anti-Infective Products Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global OTC Anti-Infective Products Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 4.3 Europe OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 4.5 South America OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    5 North America OTC Anti-Infective Products by Country

    • 5.1 North America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
      • 5.1.1 North America OTC Anti-Infective Products Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America OTC Anti-Infective Products Revenue and Market Share by Country (2014-2019)
    • 5.2 United States OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 5.3 Canada OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 5.4 Mexico OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    6 Europe OTC Anti-Infective Products by Country

    • 6.1 Europe OTC Anti-Infective Products Sales, Revenue and Market Share by Country
      • 6.1.1 Europe OTC Anti-Infective Products Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe OTC Anti-Infective Products Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 6.3 UK OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 6.4 France OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 6.5 Russia OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 6.6 Italy OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    7 Asia-Pacific OTC Anti-Infective Products by Country

    • 7.1 Asia-Pacific OTC Anti-Infective Products Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific OTC Anti-Infective Products Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific OTC Anti-Infective Products Revenue and Market Share by Country (2014-2019)
    • 7.2 China OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 7.3 Japan OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 7.4 Korea OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 7.5 India OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    8 South America OTC Anti-Infective Products by Country

    • 8.1 South America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
      • 8.1.1 South America OTC Anti-Infective Products Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America OTC Anti-Infective Products Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 8.3 Argentina OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 8.4 Colombia OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    9 Middle East and Africa OTC Anti-Infective Products by Countries

    • 9.1 Middle East and Africa OTC Anti-Infective Products Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa OTC Anti-Infective Products Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa OTC Anti-Infective Products Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 9.3 Turkey OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 9.4 Egypt OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria OTC Anti-Infective Products Sales and Growth Rate (2014-2019)
    • 9.6 South Africa OTC Anti-Infective Products Sales and Growth Rate (2014-2019)

    10 Global OTC Anti-Infective Products Market Segment by Type

    • 10.1 Global OTC Anti-Infective Products Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global OTC Anti-Infective Products Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2014-2019)
    • 10.2 Antifungals Sales Growth and Price
      • 10.2.1 Global Antifungals Sales Growth (2014-2019)
      • 10.2.2 Global Antifungals Price (2014-2019)
    • 10.3 Antiseptic Sales Growth and Price
      • 10.3.1 Global Antiseptic Sales Growth (2014-2019)
      • 10.3.2 Global Antiseptic Price (2014-2019)
    • 10.4 Antiparasitics Sales Growth and Price
      • 10.4.1 Global Antiparasitics Sales Growth (2014-2019)
      • 10.4.2 Global Antiparasitics Price (2014-2019)

    11 Global OTC Anti-Infective Products Market Segment by Application

    • 11.1 Global OTC Anti-Infective Products Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Pharmacies Sales Growth (2014-2019)
    • 11.3 Drug Stores Sales Growth (2014-2019)
    • 11.4 Retail Stores Sales Growth (2014-2019)
    • 11.5 E-Commerce Sales Growth (2014-2019)

    12 OTC Anti-Infective Products Market Forecast (2019-2024)

    • 12.1 Global OTC Anti-Infective Products Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 OTC Anti-Infective Products Market Forecast by Regions (2019-2024)
      • 12.2.1 North America OTC Anti-Infective Products Market Forecast (2019-2024)
      • 12.2.2 Europe OTC Anti-Infective Products Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific OTC Anti-Infective Products Market Forecast (2019-2024)
      • 12.2.4 South America OTC Anti-Infective Products Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa OTC Anti-Infective Products Market Forecast (2019-2024)
    • 12.3 OTC Anti-Infective Products Market Forecast by Type (2019-2024)
      • 12.3.1 Global OTC Anti-Infective Products Sales Forecast by Type (2019-2024)
      • 12.3.2 Global OTC Anti-Infective Products Market Share Forecast by Type (2019-2024)
    • 12.4 OTC Anti-Infective Products Market Forecast by Application (2019-2024)
      • 12.4.1 Global OTC Anti-Infective Products Sales Forecast by Application (2019-2024)
      • 12.4.2 Global OTC Anti-Infective Products Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on OTC Anti-Infective Products. Industry analysis & Market Report on OTC Anti-Infective Products is a syndicated market report, published as Global OTC Anti-Infective Products Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of OTC Anti-Infective Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,246.84
      4,870.26
      6,493.68
      541,314.00
      811,971.00
      1,082,628.00
      289,988.40
      434,982.60
      579,976.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report